50 anos da UNESP
Logo do repositório

Clinical Effectiveness and Safety of Vedolizumab vs. Infliximab in Biologic-Naive Ulcerative Colitis Patients: A Brazilian Real-World Multicentric Observational Study

Página do item simplificado
dc.contributor.authorFerreira, S.
dc.contributor.authorChebli, J. M. F.
dc.contributor.authorParra, R.
dc.contributor.authorSassaki, L. Yukie [UNESP]
dc.contributor.authorMello, M. K. de
dc.contributor.authorLuporini, R. L.
dc.contributor.authorChebli, L. A.
dc.contributor.authorNobrega, F. J. Firmino
dc.contributor.authorSilva, B. C. da
dc.contributor.authorDutra, R. D. M. [UNESP]
dc.contributor.authorVasconcelos, J. R. de Oliveira
dc.contributor.authorSales, M. P. Moraes
dc.contributor.authorFeres, O.
dc.contributor.authorParente, J. M. L.
dc.contributor.authorTroncon, L. E. D. A.
dc.contributor.institutionHosp Clin Ribeirao Preto
dc.contributor.institutionUniv Fed Juiz de Fora
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniv Vale Itajai
dc.contributor.institutionUniversidade Federal de São Carlos (UFSCar)
dc.contributor.institutionFed Univ Juiz De Forra
dc.contributor.institutionUniv Fed Paraiba
dc.contributor.institutionHosp Bahia
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionUniv Fed Piaui
dc.date.accessioned2025-04-29T18:04:58Z
dc.date.issued2024-01-01
dc.description.affiliationHosp Clin Ribeirao Preto, Med, Med Sch, Ribeirao Preto, Brazil
dc.description.affiliationUniv Fed Juiz de Fora, Med, Div Gastroenterol, Juiz De Fora, Brazil
dc.description.affiliationHosp Clin Ribeirao Preto, Surg & Anat, Med Sch, Ribeirao Preto, Brazil
dc.description.affiliationSao Paulo State Univ Unesp, Internal Med, Med Sch, Botucatu, SP, Brazil
dc.description.affiliationUniv Vale Itajai, Med, Itajai, SC, Brazil
dc.description.affiliationFed Univ Sao Carlos UFSCar, Med, Sao Carlos, Brazil
dc.description.affiliationFed Univ Juiz De Forra, Med, Div Gastroenterol, Juiz De Forra, Brazil
dc.description.affiliationUniv Fed Paraiba, Gastroenterol, Lauro Wanderley Hosp, Joao Pessoa, Brazil
dc.description.affiliationHosp Bahia, Gastroenterol, Salvador, Brazil
dc.description.affiliationUniv Sao Paulo, Surg & Anat, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil
dc.description.affiliationUniv Fed Piaui, Gastroenterol, Fac Med, Teresina, Brazil
dc.description.affiliationUniv Sao Paulo, Med, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil
dc.description.affiliationUnespSao Paulo State Univ Unesp, Internal Med, Med Sch, Botucatu, SP, Brazil
dc.format.extentI1087-I1088
dc.identifier.citationJournal Of Crohns & Colitis. Oxford: Oxford Univ Press, v. 18, p. I1087-I1088, 2024.
dc.identifier.issn1873-9946
dc.identifier.urihttps://hdl.handle.net/11449/296916
dc.identifier.wosWOS:001189928901052
dc.language.isoeng
dc.publisherOxford Univ Press
dc.relation.ispartofJournal Of Crohns & Colitis
dc.sourceWeb of Science
dc.titleClinical Effectiveness and Safety of Vedolizumab vs. Infliximab in Biologic-Naive Ulcerative Colitis Patients: A Brazilian Real-World Multicentric Observational Studyen
dc.typeResumopt
dcterms.licensehttp://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html
dcterms.rightsHolderOxford Univ Press
dspace.entity.typePublication
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos

Coleções

Botucatu - FMB - Faculdade de Medicina